Back to the search results

Knappschaft Kliniken Universitätsklinikum Bochum GmbH

Knappschaft Kliniken Universitätsklinikum Bochum GmbH
Knappschaft Kliniken Universitätsklinikum Bochum GmbH

In der Schornau 23-25
44892 Bochum

Phone: 0234-299-0
Fax: 0234-299-4009
Mail: ed.muhcob-kk@tkatnok

  • Number of beds: 479
  • Number of specialist departments: 12
  • Number of inpatient cases: 18.590
  • Number of outpatient cases: 49.145
  • Hospital owners: Knappschaft Kliniken Universitätsklinikum Bochum GmbH
  • Type of provider: öffentlich
  • University Hospital
  • Academic teaching hospital
External comparative quality assurance
Further information
  • External quality assurance according to state law
    No participation
  • Quality of participation in the Disease Management Programme (DMP)
    No participation
Quantity performed 109
Exception? No exception
Quantity performed 97
Exception? No exception
Quantity performed 28
Exception? No exception
Quantity performed 17
Exception? No exception
Quantity performed 67
Exception? No exception
Overall result forecast presentation: yes
Quantity performed reporting year: 109
Quantity forecast year: 50
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 97
Quantity forecast year: 96
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 28
Quantity forecast year: 35
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 17
Quantity forecast year: 17
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
Overall result forecast presentation: yes
Quantity performed reporting year: 67
Quantity forecast year: 77
Examination by state associations? yes
Exemption? yes
Result of the examination by the federal state authorities? yes
Transitional arrangement? no
No. Explanation
CQ03 Quality assurance measures for the implementation of positron emission tomography (PET) in hospitals for the indications non-small-cell lung cancer (NSCLC) and solid pulmonary nodules
CQ24 Quality assurance measures for allogeneic stem cell transplantation for multiple myeloma (valid until 30 June 2022)
CQ29
  • Clarifying chat completed: no
  • Clarifying chat not completed: no
  • No participation in clarifying chat: no
  • Notification of non-fulfilment of nursing care not made: no
Number Group
150 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
88 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
83 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.

  • Is a protection concept in place? Yes
  • No care for children and young people
Gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.
  • Drug commission

Dr. Susanne Mikle

25.10.2024

  • Bereitstellung einer geeigneten Infrastruktur zur Sicherstellung einer fehlerfreien Zubereitung
  • Zubereitung durch pharmazeutisches Personal
  • Anwendung von gebrauchsfertigen Arzneimitteln bzw. Zubereitungen
  • Vorhandensein von elektronischen Systemen zur Entscheidungsunterstützung (z.B. Meona®, Rpdoc®, AIDKlinik®, ID Medics® bzw. ID Diacos® Pharma)
  • Versorgung der Patientinnen und Patienten mit patientenindividuell abgepackten Arzneimitteln durch die Krankenhausapotheke (z.B. Unit-Dose-System)
  • Fallbesprechungen
  • Maßnahmen zur Vermeidung von Arzneimittelverwechslung
  • Spezielle AMTS-Visiten (z. B. pharmazeutische Visiten, antibiotic stewardship, Ernährung)
  • Teilnahme an einem einrichtungsübergreifenden Fehlermeldesystem (siehe Kapitel 12.2.3.2)
  • Aushändigung von arzneimittelbezogenen Informationen für die Weiterbehandlung und Anschlussversorgung der Patientin oder des Patienten im Rahmen eines (ggf. vorläufigen) Entlassbriefs
  • Aushändigung von Patienteninformationen zur Umsetzung von Therapieempfehlungen
  • Aushändigung des Medikationsplans
  • bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten
The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of ​​application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.
AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.
Job
Explanation

Explanation

Als Universitätsklinik ist das Krankenhaus vollständig in den Lehrkörper der Universität Bochum eingebunden. Neben Hauptvorlesungen und Praktika besteht ein umfangreiches begleitendes Angebot an Seminaren und Kursen aller 12 Fachdisziplinen.

Explanation

Monozentrische klinische Studien werden initiiert und durchgeführt. Es bestehen Beteiligungen an Projekten anderer Hochschulen.

Explanation

Beispiel: Collaborative Transplant Study

Explanation

In allen Fachbereichen des Hauses können die Studierenden der Medizin Famulaturen und das Praktische Jahr absolvieren.

Explanation

Explanation

Beispiele: S+L-Studie Propionat-Studie Improve Codel-Studie PRESTIGE ANNEXA-I ESCAPE NEXT SWIFT DIRECT

Explanation

Jeder Fachbereich betreut Doktoranden.

Explanation

Training in other healing professions
Comment

Weitere Informationen: https://www.kk-bochum.de/de/Karriere/Pflegefachfrau_und_Pflegefachmann/index.php

Comment

Die Theorie- und Praxisphasen können durchgeführt werden. Weitere Informationen: https://www.kk-bochum.de/de/Karriere/Pflegefachassistenz/index.php

Comment

Die Theorie- und Praxisphasen können durchgeführt werden. Die Schule für OTA/ATA ist nach AZAV zertifziert (DKG). Weitere Informationen: https://www.kk-bochum.de/de/Karriere/Anaesthesietechnische_Assistenz/index.php

Comment

Die Theorie- und Praxisphasen können durchgeführt werden. Die Schule für OTA/ATA ist nach AZAV zertifziert (DKG). Weitere Informationen: https://www.kk-bochum.de/de/Karriere/Operationstechnische_Assistenz/index.php

Comment

Weitere Informationen: https://www.kk-bochum.de/de/Karriere/Medizinische_Technologie_f%C3%BCr_Laboratoriumsanalytik/index.php

Comment

Im Rahmen der Akademisierung der Medizinischen Assistenzberufe besteht eine Kooperation mit der Hochschule für Gesundheit. Die Studierenden der Bachelor-Studiengänge Pflege, Logopädie, Physiotherapie und Ergotherapie durchlaufen die Praxiseinrichtungen unseres Hauses.

Comment

Die Praxisphase der Ausbildung kann absolviert werden.

Comment

Die Praxisphase der Ausbildung kann absolviert werden.

Manfred Sprenger

Patientenfürsprecher

In der Schornau 23-25
44892 Bochum

Phone: 0234 -299-84399
Mail: ed.muhcob-kk@tkatnok

Sylvia Ringelsiep

Feedbackmanagement

In der Schornau 23-25
44892 Bochum

Phone: 0234 -299-84009
Mail: ed.muhcob-kk@kcabdeef

Dr. med. Susanne Mikle

Qualitätsmanagementbeauftragte

In der Schornau 23-25
44892 Bochum

Phone: 0234 -299-4007
Mail: ed.muhcob-kk@mq

Univ.-Prof. Dr. Kirsten Schmieder

Ärztliche Direktorin

In der Schornau 23-25
44892 Bochum

Phone: 0234 -299-3601
Mail: ed.muhcob-kk@eigrurihcoruen

Yasmine Sieling

Leitende Apothekerin

In der Schornau 23-25
44892 Bochum

Phone: 0234 -299-890150
Mail: ed.muhcob-kk@gnileis.enimsay

Katja Wengemann

Sozialdienst

In der Schornau 23-25
44892 Bochum

Phone: 0234 -299-84200
Mail: ed.muhcob-kk@tsneidlaizos

In der Schornau 23-25
44892 Bochum

Phone: 0234-299-0
Fax: 0234-299-4009
Mail: ed.muhcob-kk@tkatnok

Kerstin Weber

Pflegedirektor

In der Schornau 23-25
44892 Bochum

Phone: 0234 -299-3902
Mail: ed.muhcob-kk@ldp

Alexandra Zimmermann

Stv. Pflegedirektorin

In der Schornau 23-25
44892 Bochum

Phone: 0234 -299-3902
Mail: ed.muhcob-kk@ldp

Dipl.-Betriebsw. Marco Kempka

Geschäftsführer

In der Schornau 23-25
44892 Bochum

Phone: 0234 -299-4001
Mail: ed.muhcob-kk@tkatnok

Dipl.-Kfm. Thomas Tatka

Kaufmännischer Direktor

In der Schornau 23-25
44892 Bochum

Phone: 0234 -299-4001
Mail: ed.muhcob-kk@tkatnok

Dipl.-Betriebsw. Marco Kempka

Geschäftsführer

In der Schornau 23-25
44892 Bochum

Phone: 0234 -299-4001
Mail: ed.muhcob-kk@tkatnok

Univ.-Prof. Dr. med. Kirsten Schmieder

Ärztliche Direktorin

In der Schornau 23-25
44892 Bochum

Phone: 0234 -299-3601
Mail: ed.muhcob-kk@eigrurihcoruen

Univ.-Prof. Dr. med. Michael Adamzik

Stv. Ärztlicher Direktor

In der Schornau 23-25
44892 Bochum

Phone: 0234 -299-3001
Mail: ed.muhcob-kk@eisehtseana

IK: 260591608

Location number: 772932000